RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Effects of TTP-PECS Block Under Opioid-Sparing General Anesthesia on Postoperative Analgesia and Early Recovery Quality in Patients Undergoing Modified Radical Mastectomy.
Effects of TTP-PECS Block Under Opioid-Sparing General Anesthesia on Postoperative Analgesia and Early Recovery Quality in Patients Undergoing Modified Radical Mastectomy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
TTP-PECS 阻滞联合羟考酮-丙泊酚阿片节俭全身麻醉可提供更优的术后镇痛效果,并降低术后恶心呕吐的发生率。同时减轻了细胞免疫功能的抑制,改善了乳腺癌患者的早期恢复质量。此外,阿片节俭全身麻醉是改良根治性乳房切除术的一种安全策略。
强效镇痛药如舒芬太尼和瑞芬太尼在全身麻醉中起着关键作用,但这些药物存在缺点,包括呼吸抑制、恶心、呕吐、免疫系统抑制和胃肠功能抑制。本研究旨在评估胸横肌平面-胸神经(TTP-PECS)阻滞对在少阿片全身麻醉下接受改良根治性乳房切除术患者术后镇痛、免疫功能和术后早期恢复质量的影响。
共100例拟在全身麻醉下行改良根治性乳房切除术的患者,随机分为TTP-PECS阻滞联合阿片类药物节约型全身麻醉组(TO组,n=50)或常规全身麻醉组(GA组,n=50)。TO组在诱导前接受TTP-PECS阻滞,诱导期间使用羟考酮作为镇痛药代替舒芬太尼,术中未额外持续输注镇痛药。记录两组患者不同时间点静息和运动时的视觉模拟评分(VAS),并测定手术前及手术后24 h和48 h的T细胞亚群、自然杀伤(NK)细胞水平。术后24 h评估Quality of Recovery-40(QoR-40)评分,并观察两组围术期不良反应的发生率。
除术后48 h外,TO组患者在术后2 h、6 h、12 h和24 h静息及运动时的VAS评分均显著低于GA组(P < 0.05)。术后24 h和48 h,TO组CD4 + T细胞表达及CD4 + /CD8 + 比值显著高于GA组(P < 0.05)。术后24 h评估的QoR-40量表显示,TO组在总分以及情绪状态、身体舒适度、身体独立性、心理支持和疼痛子评分方面均显著优于GA组(P < 0.05)。此外,两组在T1-T4时间点的收缩压(SBP)、舒张压(DBP)和心率(HR)均低于T0(P < 0.05),但两组间差异无统计学意义(P > 0.05)。TO组诱导期咳嗽反射发生率及术后恶心呕吐发生率均显著低于GA组(P < 0.05)。两组其他不良反应发生率差异无统计学意义(P > 0.05)。
A total of 100 patients scheduled for modified radical mastectomy under general anesthesia were randomly divided into the TTP-PECS block combined with opioid-sparing general anesthesia group (TO group, n = 50) or the conventional general anesthesia group (GA group, n = 50). The TO group underwent TTP-PECS block prior to induction, using oxycodone as the analgesic during induction instead of sufentanil, no additional continuous infusion of analgesic was performed intra-operatively. Visual analogue scale (VAS) scores at rest and during movement at different time points were recorded in both groups, and the levels of T cell subsets, natural killer (NK) cells were measured before the surgery and at 24 h and 48 h after the surgery. Quality of Recovery-40 (QoR-40) scores were assessed at 24 h postoperatively, and the incidence of peri-operative adverse reactions was also observed in both groups.
Except for 48 h postoperatively, patients in the TO group had significantly lower VAS scores than those in the GA group at 2 h, 6 h, 12 h, and 24 h postoperatively at rest and during movement (P < 0.05). At 24 h and 48 h postoperatively, the expression of CD4 + T cells and the CD4 + /CD8 + ratio were significantly higher in the TO group than in the GA group (P < 0.05). The QoR-40 scale, assessed at 24 h postoperatively, showed that the TO group significantly outperformed the GA group in total scores as well as in sub-scores for emotional state, physical comfort, physical independence, psychological support, and pain (P < 0.05). In addition, systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR) were lower at time points T1-T4 than at T0 in both groups (P < 0.05), but the differences between the two groups were not statistically significant(P > 0.05). The incidence of cough reflex during induction and postoperative nausea and vomiting were significantly lower in the TO group than in the GA group (P < 0.05). There was no statistically significant difference between the two groups in the incidence of other adverse reactions (P > 0.05).
The combination of TTP-PECS block and oxycodone-propofol opioid-sparing general anesthesia can provide superior postoperative analgesia and reduce the incidence of postoperative nausea and vomiting. It also alleviated the suppression of cellular immune function and improves the quality of early recovery in breast cancer patients. At the same time, opioid-sparing general anesthesia is a safe strategy for modified radical mastectomy. TRIAL REGISTRATION: Chinese Clinical Trial Registry; ChiCTR2200066753.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。